Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PubMed

The illusion of safety: A report to the FDA on AI healthcare product approvals.

PMID: 40471897 ·

R, a, w, a, n, , A, b, u, l, i, b, d, e, h, ;, , L, e, o, , A, n, t, h, o, n, y, , C, e, l, i, ;, , E, r, v, i, n, , S, e, j, d, i, ć

RevistaPLOS digital health
Año
PMID40471897

Resumen

Artificial intelligence is rapidly transforming healthcare, offering promising advancements in diagnosis, treatment, and patient outcomes. However, concerns regarding the regulatory oversight of artificial intelligence driven medical technologies have emerged, particularly with the U.S. Food and Drug Administration's current approval processes. This paper critically examines the U.S. Food and Drug Administration's regulatory framework for artificial intelligence powered healthcare products, high

Fuente oficial

Ver en PubMed →

Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.

↑